A Maryland biotech company has taken an important next step in their HIV Clinical Trial that they hope will lead to long-term remission for participants. Rockville-based biotech company American Gene Technologies® has begun withdrawing clinical trial participants from their antiretroviral HIV medication to determine whether the gene therapy treatment works. All 7 participants have already shown safety and blood markers of efficacy, according to the press release. Full press release below:
The Gene Therapy Industry Is Poised for Enormous Growth